FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to gynecology, and is intended for the diagnosis of external genital endometriosis. In the blood plasma, the number of microvesicles of leukocyte origin with the CD54+CD14+ phenotype is determined. With their content of 5.22% and above, external genital endometriosis is diagnosed.
EFFECT: invention provides an expansion of the arsenal of tools, an increase in the specificity and accuracy of early non-invasive diagnosis of external genital endometriosis.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSIS OF EXTERNAL GENITAL ENDOMETRIOSIS | 2021 |
|
RU2756027C1 |
| METHOD FOR DIAGNOSTICS OF INITIAL FORMS OF EXTERNAL GENITAL ENDOMETRIOSIS | 2022 |
|
RU2793841C1 |
| METHOD FOR DIAGNOSIS OF EARLY STAGES OF EXTERNAL GENITAL ENDOMETRIOSIS | 2015 |
|
RU2592240C1 |
| METHOD FOR PREDICTION OF EXTERNAL GENITAL ENDOMETRIOSIS IN PATIENTS WITH TYPE 1 DIABETES MELLITUS USING NOMOGRAMS | 2023 |
|
RU2814561C1 |
| DIAGNOSTIC TECHNIQUE FOR EXTERNAL GENITAL ENDOMETRIOSIS | 2013 |
|
RU2526823C1 |
| DIAGNOSTIC TECHNIQUE IN ENDOMETRIOID OVARIAN CYSTS | 2012 |
|
RU2480761C1 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2019 |
|
RU2732251C1 |
| METHOD OF DIAGNOSTICS OF ENDOMETRIOSIS IN WOMEN WITH INFERTILITY | 2017 |
|
RU2657802C1 |
| WAY OF DIAGNOSTICS OF EXTERNAL GENITAL ENDOMETRIOSIS | 2008 |
|
RU2363001C1 |
| METHOD FOR PREDICTING EXTERNAL GENITAL ENDOMETRIOSIS | 2004 |
|
RU2265223C1 |
